Clinical Trial Update: Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols [Phase 4]

View source ↗

Summary

A Phase 4 trial completed to investigate genetic factors that drive variability in plasma lipid response to plant sterols.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Plant sterols (phytosterols)

Snippet

Sponsor: University of Manitoba | Conditions: Hyperlipidemia | Phase 4 | Status: COMPLETED